nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of image-derived input functions from small vessels for patlak parametric imaging using total-body PET/CT
|
Tang, Hongmei |
|
|
52 |
2 |
p. 648-659 |
artikel |
2 |
Characterization of a gonadal vein Capillary Hemangioma by [68Ga]FAPI-46 and [18 F]FDG PET and immunohistochemistry: a potential pitfall of FAPI PET signal
|
Hotta, Masatoshi |
|
|
52 |
2 |
p. 785-786 |
artikel |
3 |
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer
|
Ahmadi Bidakhvidi, Niloefar |
|
|
52 |
2 |
p. 766-778 |
artikel |
4 |
Considerations for SUV measurement in PSMA PET/CT reporting: a call for standardisation and best practices
|
de Keizer, Bart |
|
|
52 |
2 |
p. 386-387 |
artikel |
5 |
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
|
Collij, Lyduine E. |
|
|
52 |
2 |
p. 782-784 |
artikel |
6 |
Development and characterisation of [18F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates
|
Wang, Jing |
|
|
52 |
2 |
p. 416-426 |
artikel |
7 |
Development of STING probes and visualization of STING in multiple tumor types
|
Liu, Huanhuan |
|
|
52 |
2 |
p. 401-415 |
artikel |
8 |
Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma
|
Ma, Jie |
|
|
52 |
2 |
p. 599-610 |
artikel |
9 |
EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0
|
Abikhzer, Gad |
|
|
52 |
2 |
p. 510-538 |
artikel |
10 |
Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
|
Ceuppens, Hannelore |
|
|
52 |
2 |
p. 444-457 |
artikel |
11 |
Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04
|
Zheng, Zhe |
|
|
52 |
2 |
p. 638-647 |
artikel |
12 |
False-positive 16α-[18F]Fluoro-17β-Estradiol PET/CT in benign cartilaginous tumor
|
Mazet, Réjane |
|
|
52 |
2 |
p. 779-781 |
artikel |
13 |
Ferdinando Calabria, Orazio Schillaci (editors). Radiopharmaceuticals. A guide to PET/CT and PET/MRI, 3rd edition. Springer Nature Switzerland AG 2024. ISBN 978-3-031-54195-7
|
Mansi, Luigi |
|
|
52 |
2 |
p. 375 |
artikel |
14 |
[18F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients
|
Hu, Daoyan |
|
|
52 |
2 |
p. 564-573 |
artikel |
15 |
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
|
Schmidt, I. |
|
|
52 |
2 |
p. 660-668 |
artikel |
16 |
[68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study
|
Chen, Yun |
|
|
52 |
2 |
p. 683-692 |
artikel |
17 |
ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study
|
Xu, Dongsheng |
|
|
52 |
2 |
p. 388-400 |
artikel |
18 |
Impact of different parametric Patlak imaging approaches and comparison with a 2-tissue compartment pharmacokinetic model with a long axial field-of-view (LAFOV) PET/CT in oncological patients
|
Pan, Leyun |
|
|
52 |
2 |
p. 623-637 |
artikel |
19 |
Long-term trends in total administered radiation dose from brain [18F]FDG-PET in children with drug-resistant epilepsy
|
Gennari, Antonio G. |
|
|
52 |
2 |
p. 574-585 |
artikel |
20 |
Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
|
Shiri, Isaac |
|
|
52 |
2 |
p. 485-500 |
artikel |
21 |
New horizons for the World Federation of Nuclear Medicine and Biology: achievements, partnerships, and future directions
|
Frangos, Savvas |
|
|
52 |
2 |
p. 376-379 |
artikel |
22 |
Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model
|
Yaginuma, Kei |
|
|
52 |
2 |
p. 469-481 |
artikel |
23 |
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
|
Thunold, Solfrid |
|
|
52 |
2 |
p. 693-707 |
artikel |
24 |
PET/CT with [68Ga]Ga-TEoS-DAZA for localization of a traumatic biliary leak
|
Freesmeyer, Martin |
|
|
52 |
2 |
p. 787-789 |
artikel |
25 |
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer
|
Wijngaarden, Jessica E. |
|
|
52 |
2 |
p. 719-729 |
artikel |
26 |
Preclinical evaluation and pilot clinical study of [68Ga]Ga-NOTA-H006 for non-invasive PET imaging of 5T4 oncofetal antigen
|
He, Yingfang |
|
|
52 |
2 |
p. 611-622 |
artikel |
27 |
Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy
|
Holzleitner, Nadine |
|
|
52 |
2 |
p. 458-468 |
artikel |
28 |
Pre-operative dual-time-point [18F]FET PET differentiates CDKN2A/B loss and PIK3CA mutation status in adult-type diffuse glioma: a single-center prospective study
|
Lee, Dong Yun |
|
|
52 |
2 |
p. 669-682 |
artikel |
29 |
Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer
|
Seban, Romain-David |
|
|
52 |
2 |
p. 708-718 |
artikel |
30 |
Quantitative aortic Na[18F]F positron emission tomography computed tomography as a tool to associate vascular calcification with major adverse cardiovascular events
|
Lieverse, T. G. F. |
|
|
52 |
2 |
p. 501-509 |
artikel |
31 |
Radioiodine-refractory thyroid cancer—is it time to change the definition in light of novel redifferentiation therapies?
|
Petranović Ovčariček, Petra |
|
|
52 |
2 |
p. 380-385 |
artikel |
32 |
Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease
|
Combes, Benjamin F. |
|
|
52 |
2 |
p. 427-443 |
artikel |
33 |
Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases
|
Lugat, Alexandre |
|
|
52 |
2 |
p. 730-743 |
artikel |
34 |
The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer
|
Guo, Shikuan |
|
|
52 |
2 |
p. 756-765 |
artikel |
35 |
Updated practice guideline for dual-energy X-ray absorptiometry (DXA)
|
Slart, Riemer H. J. A. |
|
|
52 |
2 |
p. 539-563 |
artikel |
36 |
Utility of pre-procedural [99mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of 90Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [99mTc]TcMAA-based Segmentation
|
Lam, Marnix |
|
|
52 |
2 |
p. 744-755 |
artikel |
37 |
Utilizing artificial intelligence to detect cardiac amyloidosis in patients with severe aortic stenosis: A step forward to diagnose the underdiagnosed
|
Muller, Steven A |
|
|
52 |
2 |
p. 482-484 |
artikel |
38 |
Visual reading for [18F]Florzolotau Tau PET scans in progressive supranuclear palsy
|
Liu, Feng-Tao |
|
|
52 |
2 |
p. 586-598 |
artikel |